Aller au contenu principal
Profil bibliographique

William Savigne-Gutiérrez

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
171Citations signalées
0Affiliations récentes

Les domaines associés

Wound Healing and TreatmentsDiabetic Foot Ulcer Assessment and ManagementPressure Ulcer Prevention and ManagementMesenchymal stem cell researchTendon Structure and Treatment

Les publications récentes

Accès ouvert 2025 article OpenAlex

Major Common Hallmarks and Potential Epigenetic Drivers of Wound Chronicity and Recurrence: Hypothesis and Reflections

Alicia María Tamayo Carbón, Ariana García Ojalvo, José I Fernández‐Montequín, William Savigne-Gutiérrez et autres

Chronic wounds are considered a silent epidemic that impact millions of human lives worldwide, causing comorbidities, reducing life quality and expectancy. Diabetic, pressure, and venous ulcers are the three major clinical entities of chronic wounds, in which the presence of a chronicity …

cu (code pays fourni par la source)

3 citations International Journal of Molecular Sciences
Accès ouvert 2022 review OpenAlex

A narrative review on Epidermal Growth Factor (EGF) intralesional infiltrations for diabetic complex wounds: The rational of an innovative delivery route

Jorge Berlanga‐Acosta, Jose Fernandez-Montequin, Héctor Santana-Milián, Calixto Valdes-Perez et autres

Diabetes mellitus remains as a pandemic disease, associated to progressive and irreversible complications including lower extremity ulcerations, derived from a predisposition to ischemia, neuropathy and an intrinsic wound healing failure. The molecular operators supporting wound chronicity remain elusive, but a local deficit …

cu, es (code pays fourni par la source)

2 citations Vascular Diseases and Therapeutics
Accès ouvert 2017 article OpenAlex

Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome

Jorge Berlanga‐Acosta, José I Fernández‐Montequín, Calixto Valdés‐Perez, William Savigne-Gutiérrez et autres

Soon after epidermal growth factor (EGF) discovery, somein vivomodels appeared demonstrating its property to enhance cutaneous wound healing. EGF was the first growth factor (GF) introduced in the clinical arena as a healing enhancer, exerting its mitogenic effects on epithelial, fibroblastoid, and …

cu, il (code pays fourni par la source)

66 citations BioMed Research International
Accès ouvert 2012 article OpenAlex

Detrimental impact of acute and chronic glucose burden in wound-healing cells: fibroblasts, myofibroblasts and vascular precursor cells

Jorge Berlanga‐Acosta, Ernesto López‐Mola, Marianela García-Siverio, Gerardo E Guillén et autres

Type 2 diabetes mellitus comprises a group of non-communicable metabolic diseases with an expanding pandemic magnitude. Diabetes predisposes to lower extremities ulceration and impairs the healing process leading to wounds chronification. Diabetes also dismantles innate immunity favoring wound infection. Amputation is therefore …

cu (code pays fourni par la source)

1 citation DOAJ (DOAJ: Directory of Open Access Journals)
Accès ouvert 2010 article OpenAlex

Cellular and molecular insights into the wound healing mechanism in diabetes

Jorge Berlanga‐Acosta, Calixto Valdéz-Pérez, William Savigne-Gutiérrez, Yssel Mendoza‐Marí et autres

Impaired healing in diabetes affects the resolution of both acute and chronic wounds. The vicious circle between wound chronicity and a deficient control of local infection is the cause that diabetic patients constitute 85% of all non-traumatic lower extremity amputations. From an …

cu (code pays fourni par la source)

19 citations DOAJ (DOAJ: Directory of Open Access Journals)
Accès ouvert 2007 article OpenAlex

Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation

José I Fernández‐Montequín, Ena Infante‐Cristiá, Carmen Valenzuela‐Silva, Neobalis Franco‐Pérez et autres

To investigate the efficacy and safety of recombinant human epidermal growth factor (rhEGF) in advanced diabetic foot ulcers (DFU) A double-blind trial was carried out to test two rhEGF dose levels in type 1 or 2 diabetes patients with Wagner's grade 3 …

cu (code pays fourni par la source)

80 citations International Wound Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.